Source: Annual Congress 2010 - New diagnostic approaches in respiratory function



Rating:

Share or cite this content

Citations should be made in the following way:
J. P. Oliveira, D. M. Goto, R. Mendonça, C. Fló, P. H. N. Saldiva, G. Lorenzi-Filho, N. K. Nakagawa (Brazil). Aging, and not diabetes or hypertension, induces mucociliary clearance dysfunction in a general population. Eur Respir J 2010; 36: Suppl. 54, 1059

Member's Comments

No comment yet.

Related content which might interest you: Prevalence and outcomes of diabetes, hypertension and cardiovascular disease in COPD Source: Eur Respir J 2008; 32: 962-969 Year: 2008 Diseases associated with restrictive lung function impairment Source: Eur Respir Mon; 2009: 43: 142–149 Year: 2009 Cardiovascular comorbidities based on impaired pulmonary function in non-smoking population Source: Virtual Congress 2020 – Airflow obstruction, COPD and comorbidities Year: 2020 The effect of obesity and central obesity on pulmonary function of asthmatics Source: Annual Congress 2008 - Markers and triggers of asthma Year: 2008 Metabolic syndrome and diabetes mellitus in COPD Source: Eur Respir Mon 2013; 59: 117-134 Year: 2013 Decline of the lung function and quality of glycemic control in type 2 diabetes mellitus Source: Annual Congress 2013 –Novel biomarkers and old parameters in clinical management of lung diseases Year: 2013 Inadequate glucose control in type 2 diabetes is associated with impaired lung function and with systemic inflammation Source: Annual Congress 2009 - Comorbidities and case management in primary respiratory care Year: 2009 Impaired cardiac autonomic control relates to disease severity in pulmonary hypertension Source: Eur Respir J 2009; 34: 895-901 Year: 2009 Relationship between lung function impairment and incidence or recurrence of cardiovascular disease in a middle-aged cohort Source: Annual Congress 2007 - Longitudinal and cross sectional risk factors for COPD Year: 2007 May impairment of mucociliary clearance in COPD be reversible? Source: Annual Congress 2013 –COPD and tobacco management Year: 2013 Obesity and pulmonary hypertension Source: Eur Respir Mon 2012; 57: 194-207 Year: 2012 The prevalence of chronic obstructive pulmonary disease (COPD) in individuals with diabetes, hypertension, asthma, or mood/anxiety disorders: A Canadian population study Source: Annual Congress 2012 - Asthma and COPD: quality of life and comorbidities Year: 2012 The prevalence and characteristics of pulmonary hypertension in severe COPD Source: International Congress 2016 – Pulmonary hypertension in lung disease Year: 2016 Impact of pulmonary function on cardiovascular disease events in persons with metabolic syndrome and diabetes Source: Annual Congress 2011 - Comorbidities and impact on society of asthma and COPD Year: 2011 The impact of aging on COPD, cardiovascular comorbidities and systemic inflammation Source: International Congress 2019 – Cardiovascular comorbidities in COPD Year: 2019 Determinants of prognosis of COPD in the elderly: mucus hypersecretion, infections, cardiovascular comorbidity Source: Eur Respir J 2003; 21: 10S-14S Year: 2003 Autonomic neuropathy: a risk factor of accelerated decline of the respiratory function in diabetic patients? Source: Eur Respir J 2003; 22: Suppl. 45, 47s Year: 2003 Asthma in the elderly Source: Eur Respir Mon; 2009: 43: 56–76 Year: 2009 Lung function impairment in adult asthma increases the risk of systemic inflammation Source: International Congress 2015 – Immune aspects of asthma and other airway diseases Year: 2015 Adults with cystic-fibrosis related diabetes have lower pulmonary function and more infections Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems Year: 2012